## KEYS: Keysight Technologies Inc. - XLK: Technology

### Executive Summary

STRENGTH thesis confirmed: MRS_10 at 5.5% in upper entry zone (3.0-6.0%), top 9% cross-sectional ranking. Short-term MRS_5 (2.1%) confirms momentum alignment. Outperforming sector by 5.2%. Caution: overbought RSI (76).

- **Horizon:** 5-20 days (swing)
- **Risk Profile:** Moderate - momentum continuation
- **Stop Type:** Fixed 2xATR ($198.83)
- **If Wrong:** Exit if MRS_10 drops below entry zone or breaks stop
- **Invalidation:** MRS_10 exits entry zone or MRS_5 turns negative

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 8, Bearish: 0)

**1. KEYS: AI-driven Wireline growth, margin expansion, and disciplined M&A fuel Keysight's momentum**
- Source: TradingView | 20251204T152227 | Bullish | Relevance: 99%
-  Keysight's competitive advantage stems from trust, client integration, and a first-to-market approach. Recent growth is fueled by AI demand in Wireline, strong financial discipline, and strategic M&A, with further margin expansion expected. This information is based on an AI-generated summary of Keysight Technologies Inc.'s Citi Annual Global Healthcare Conference audio transcript from December 4, 2025.

**2. Arrowstreet Capital Limited Partnership Increases Position in Keysight Technologies Inc. $KEYS**
- Source: MarketBeat | 20251204T085214 | Bullish | Relevance: 99%
- Arrowstreet Capital Limited Partnership significantly increased its stake in Keysight Technologies Inc. by 26.2% in the second quarter, bringing its total holding to 662,168 shares valued at approximately $108.5 million. This increase comes as Keysight Technologies reported strong quarterly earnings, beating analyst expectations, and authorized a $1.5 billion share buyback program. The stock is currently trading near its 12-month high, with several analysts upgrading their ratings and setting higher price targets.

**3. Keysight Technologies stock hits 52-week high at 201.66 USD By Investing.com**
- Source: Investing.com Australia | 20251203T071600 | Bullish | Relevance: 98%
- Keysight Technologies (KEYS) stock reached a new 52-week high of $201.66, reflecting a 17.77% increase over the last year and strong investor confidence. The company reported robust fiscal fourth-quarter results, with revenue and EPS surpassing expectations, and analysts from UBS, Baird, Wells Fargo, Jefferies, and Goldman Sachs maintaining positive outlooks and price targets, largely driven by growth in AI and data center markets.

**4. Insider Selling: Keysight Technologies (NYSE:KEYS) CEO Sells 12,528 Shares of Stock**
- Source: MarketBeat | 20251204T124952 | Somewhat-Bullish | Relevance: 98%
- Keysight Technologies CEO Satish Dhanasekaran sold 12,528 shares of the company's stock for approximately $2.46 million, reducing his ownership by 8.65%. This transaction comes after the company reported strong Q3 earnings, beating analyst estimates, and authorized a $1.5 billion share buyback program. Analysts maintain a generally positive outlook for Keysight Technologies, with a consensus price target of $214.82.

**5. Keysight Introduces New Handheld Analyzer Enabling 120-MHz IQ Streaming for Gap-Free Signal Capture**
- Source: Markets Financial Content | 20251204T110000 | Bullish | Relevance: 98%
-  Keysight Technologies, Inc. has launched the N99xxD-Series FieldFox Handheld Analyzer, featuring 120 MHz gap-free IQ streaming and high-speed data transfer to address challenges in complex RF environments. This new device offers advanced wideband signal analysis, enabling engineers to capture and analyze signals with high precision in various critical applications. The analyzer also integrates AI capabilities for faster classification of wireless standards and improved spectrum management.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 10, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-26 | Baird | $210 | $205 | +2% |
| 2025-11-25 | Jefferies | $195 | $180 | +8% |
| 2025-11-25 | Citigroup | $220 | $215 | +2% |
| 2025-11-25 | UBS | $230 | $220 | +5% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-26 | Baird | main | Outperform |
| 2025-11-25 | Jefferies | main | Hold |
| 2025-11-25 | Citigroup | main | Buy |
| 2025-11-25 | UBS | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 12 ($0.00M) |
| Sells | 41 ($15.96M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 50.5% |
| Smart Money | **NEUTRAL** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 12.5% (+0.5%)
- Price (T.Rowe) Assoc: 10.1% (-8.6%)
- Blackrock Inc.: 9.8% (+1.9%)
- State Street Corpora: 4.7% (+0.2%)
- Geode Capital Manage: 3.0% (+12.7%)

### Key Risks

1. Heavy insider selling: $16M sold (41 transactions in 90 days).
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Analyst target momentum: 10 raises (avg +9%) could attract flows.
- AI/machine learning initiatives could drive multiple expansion if executed.

### Fundamentals

PEG ratio 1.09 suggests fair value with growth premium. Quality metrics strong (margin 16%). Balance sheet: strong liquidity (2.4x). Analyst sentiment positive (10 raises, avg +9%). Insider selling cluster ($16.0M in 90 days), potential headwind.

| Metric | Value |
|--------|-------|
| Market Cap | $36.2B |
| Beta | 1.20 |
| 52W Range | $121.43 - $212.93 |
| Short Interest | 2.5% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.09 |
| Forward P/E | 22.7 |
| Current P/E | 26.0 |
| YoY Growth | 14.4% |
| EPS Direction | STABLE |

### Technicals

MRS_10 stable at 5.5% (minimal 5-day change). Currently in upper STRENGTH zone (3.0-6.0%), cross-sectional ranking at 91st percentile. MRS_5 at 2.1% confirms short-term momentum alignment. Outperforming sector by 5.2pp, stock-specific strength. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (2.84), confirming momentum. RSI overbought at 76, risk of mean reversion.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 5.46% (CS: 91) | Strong |
| RSI_14 | 76.3 | Overbought |
| MACD Histogram | 2.84 | Bullish |
| vs SMA20 | 1.123x | Above |
| vs SMA50 | 1.184x | Above |
| vs SMA200 | 1.287x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** STRENGTH

### Trade Setup

- **Entry:** $210.49
- **Stop Loss:** $198.83 (5.5% risk)
- **Target:** $227.98 (R:R method)
- **Risk/Reward:** 1.50:1
- **Target Reasoning:** STRENGTH thesis targets 1.5x risk/reward based on historical edge

### Position Sizing

- **Shares:** 85
- **Position Value:** $17,891.65
- **Portfolio %:** 17.89%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate risk appetite persisting. Mixed earnings signals with industrial weakness (John Deere) offset by consumer/tech strength, while institutional flows show selective positioning rather than broad risk-off. Fed meeting in 9 days provides near-term catalyst but current data suggests status quo maintenance.*

### Earnings

**Next:** 2026-02-24 (Est: $1.99)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $1.83 | $1.91 | +4.2% |
| 2025Q3 | $1.67 | $1.72 | +2.9% |
| 2025Q2 | $1.65 | $1.70 | +3.3% |
| 2025Q1 | $1.69 | $1.82 | +7.6% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*